1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. INOGEN INC
243.8K
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Inogen Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Inogen Inc share price target, revenues, EPS, net income and more

Inogen Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Inogen Inc Jun-2026 Quarterly Revenue is $95 Million which is growth of 3.0% YoY.

  • POSITIVE

    Quarterly Net Profit Inogen Inc Jun-2026 Quarterly Net Profit is $-4 Million which is growth of 7.3% YoY.

Inogen Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
95.185.181.792.492.382.380.188.888.87875.98483.6
Cost Of Rev.
51.847.346.551.150.945.943.847.54643.747.750.249.6
Gross Profit
43.337.935.241.341.336.436.341.342.734.428.233.834
⌄
48.447.244.548.447.54447.749.149.850.657.147.645.8
Operating Profit
-5.1-9.3-9.3-7.1-6.1-7.7-11.4-7.8-7.1-16.3-29-13.8-11.8
0.90.91.21.11.111.411.31.41.61.81.7
Profit Before Tax
-4-8.5-7.4-5.4-4.3-6.3-10.1-6.1-5.6-14.7-27.1-45.3-9.8
Tax
-0.2-0.2-0.2-0.2-0.2-0.1-0.3-0.1-0-0.2-0.50.40
⌄
-3.9-8.3-7.1-5.3-4.2-6.2-9.8-6-5.6-14.6-26.6-45.7-9.8
Diluted NI Avail to Com Stockholders Ann.
-3.9-8.3-7.1-5.3-4.2-6.2-9.8-6-5.6-14.6-26.6-45.7-9.8
Basic EPS
-0.1-0.3-0.3-0.2-0.2-0.3-0.4-0.3-0.2-0.6-1.1-2-0.4
Diluted EPS After ExtraOrdinary
-0.1-0.2-0-0-0.1-0.2-0.1-0.1-0.5-0.8-0.4-0.3
Number Of Shares End
27.127.327.227.12725.223.923.823.623.423.323.223.2
Net Income Continuing Discontinued Operations
-3.9-8.3-7.1-5.3-4.2-6.2-9.8-6-5.6-14.6-26.6-45.7-9.8
Normalized Income
-0-4-4-0.5-0.7-2.9-5.8-2.6-1.6-10.4-19.4-8.5-5.8
Interest Income
0.90.91.21.11.111.411.31.41.61.81.7
Interest
-------------
Net Interest Income
0.90.91.21.11.111.411.31.41.61.81.7
EBIT
-4.9-9.4-8.5-6.5-5.4-7.3-11.5-7.1-6.9-16.1-28.7-47.1-11.4
EBITDA
-0.2-4.5-3.5-1.3-0.2-2.1-6.4-1.8-2.8-10.9-23.6-42.5-7.1
Reconciled Cost Of Rev.
51.847.346.551.150.945.943.847.54643.747.750.249.6
Reconciled Depr.
4.74.955.25.25.25.15.35.35.35.14.64.3
Profit From Continuing Operations
-3.9-8.3-7.1-5.3-4.2-6.2-9.8-6-5.6-14.6-26.6-45.7-9.8
Normalized EBITDA
-0.4-4.4-4.3-1.9-0.9-2.5-6.3-2.5-1.7-11-23.823.7-7.5
*All financials are in USD Million and price data in USD

Inogen Inc competitor comparison and performance snapshot within industry

Inogen Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue Inogen Inc Dec-2025 Annual Revenue is $349 Million which is growth of 3.9% YoY.

  • POSITIVE

    Annual Net Profit Inogen Inc Dec-2025 Annual Net Profit is $-23 Million which is growth of 36.6% YoY.

Inogen Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-2.6%
2.5%
 348.7335.7315.7377.2358308.5361.9358.1249.4202.8159
Cost Of Rev. Ann.
-4.6%
2.7%
196.6194.4181189223.7181.5170.3190.1179.5128.2105.582.8
Gross Profit Ann.
0.2%
2.2%
157.7154.3154.7126.7153.5176.5138.2171.9178.6121.297.376.3
Operating Exp. Ann.
-0.4%
4.2%
188.5184.5197.3203.2186.6167.2150.2152.1140.793.774.561.2
Operating Profit Ann.
-
-
-30.9-30.2-42.5-76.5-33.19.2-1219.837.927.622.915.1
16.3%
37.4%
44.45.26.62.80.10.94.73.30.80.20.1
Other Exp. Ann.
-
-16.2%
 2.40.9-32.4-53-0.75.8-0.2-0.71.3-0.3-0.4
PBT Ann.
-
-
-25.3-23.4-36.5-102.3-83.38.7-5.324.340.529.722.714.7
Tax Ann.
-
-
-0.7-0.6-0.60.10.5150.63.3-11.48.72.23.1
⌄
-
-
-24.6-22.8-35.9-102.5-83.8-6.3-5.82151.82120.511.6
Diluted NI Avail to Com Stockholders Ann.
-
-
-24.6-22.8-35.9-102.5-83.8-6.3-5.82151.82120.511.6
EPS Ann.
-
-
 -0.9-1.5-4.4-3.7-0.3-0.312.4110.6
Diluted EPS Ann.
-
-
 -0.9-1.5-4.4-3.7-0.3-0.30.92.3110.6
Number Of Shares End
5.9%
4.3%
 27.223.923.322.922.72221.921.520.920.319.7
Total Exp. Ann.
-2.6%
3.4%
 378.9378.2392.2410.3348.8320.5342.2320.2221.9180144
Net Income Continuing Discontinued Operations Ann.
-
-
-24.6-22.8-35.9-102.5-83.8-6.3-5.82151.82120.511.6
Normalized Income Ann.
-
-
-8.5-8-20.4-48.3-26.32.70.72151.828.620.510
Interest Income Ann.
16.3%
37.4%
44.45.26.62.80.10.94.73.30.80.20.1
Interest Ann.
-
-
 -------00
EBITDA Ann.
-
-
-9.4-7.1-20.7-90.8-62.630.212.433.448.541.236.128.7
Reconciled Cost Of Rev. Ann.
-4.6%
2.7%
196.6194.4181189223.7181.5170.3190.1179.5128.2105.582.8
Reconciled Depr. Ann.
-4.1%
2.2%
19.920.72118.223.521.618.613.811.312.313.614
Profit From Continuing Operations Ann.
-
-
-24.6-22.8-35.9-102.5-83.8-6.3-5.82151.82120.511.6
Normalized EBITDA Ann.
-
-
-11-9.6-21.5-25.542.630.96.633.651.84236.328.8
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
3.9%
2Y CAGR
5.1%
3Y CAGR
-2.6%
5Y CAGR
2.5%
7Y CAGR
-0.4%
10Y CAGR
8.2%
Total Revenue Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
-6.5%
2Y CAGR
-4.7%
3Y CAGR
-0.4%
5Y CAGR
4.2%
7Y CAGR
3.9%
10Y CAGR
11.7%
Operating Expenses Annual Cr is falling faster than historical averages.

Inogen Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Inogen Inc Dec-2025 Total Shareholders Fund is $192 Million which is growth of 10.6% YoY.

  • POSITIVE

    Total Assets Inogen Inc Dec-2025 Total Assets is $299 Million which is growth of 0.8% YoY.

Inogen Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-9.7%
-8.4%
298.6296.2326.2405489.5461.9447.3375.9275.1214.1161.3
⌄
-0.4%
-1.1%
106.4122.3121.4107.6119.3112.2102.765.5483227.3
⌄
-13.5%
-11.3%
192.2173.9204.8297.4370.2349.6344.6310.4227182.1134
Total Capitalization Ann.
-13.5%
-11.3%
192.2173.9204.8297.4370.2349.6344.6310.4227182.1134
Tangible Assets Ann.
-17.1%
-9.4%
150.8133.9160.2264.4277.1247.7234.1304.4220181.9133.8
Working Capital Ann.
-17.4%
-11.5%
134.8108.8134.6239.3267.7249242268194.6138.792.8
Invested Capital Ann.
-13.5%
-11.3%
192.2173.9204.8297.4370.2349.6344.6310.4227182.1134.3
Tangible Book Value Ann.
-17.1%
-9.4%
150.8133.9160.2264.4277.1247.7234.1304.4220181.9133.8
Borrowings Ann.
-9.1%
11.8%
17.519.421.923.326.7106.7---0.3
Net Debt Ann.
-
-
-----------
Share Issued Ann.
5.9%
4.2%
27.223.922.922.922.722.12221.82120.419.8
Number Of Shares End
5.9%
4.3%
27.223.923.322.922.72221.921.520.920.319.7
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
0.8%
2Y CAGR
-4.3%
3Y CAGR
-9.7%
5Y CAGR
-8.4%
7Y CAGR
-3.2%
10Y CAGR
6.4%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-17.2%
2Y CAGR
-6.4%
3Y CAGR
-1%
5Y CAGR
2.3%
7Y CAGR
4.5%
10Y CAGR
11.2%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
10.5%
2Y CAGR
-3.1%
3Y CAGR
-13.5%
5Y CAGR
-11.3%
7Y CAGR
-6.6%
10Y CAGR
3.7%
Total ShareHolders Funds Annual growth is higher than historical averages.

Inogen Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Inogen Inc Book Value Per Share is $7 which is growth of -4.3% YoY.

  • NEUTRAL

    ROE Inogen Inc ROE is 0% which is growth of 0% YoY.

Inogen Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--11.53%-28.02%-18.73%-1.33%-1.28%5.09%15.93%8.59%10.93%7.69%
ROE Ann. %
-
-
--18.95%-40.80%-25.10%-1.76%-1.68%6.40%19.29%10.27%12.98%9.19%
ROIC %
-
-
--5.6-11.7-16.7-5.6-1.4-0.63.1-0.45.62.9
OPM Ann. %
-
-
-8.66%-12.66%-24.23%-8.77%2.58%-3.90%5.47%10.58%11.06%11.27%9.47%
Inventory Turnover Ratio Ann.
-
-
-7.86.86.86.45.66.17.87.79.210.2
Asset Turnover Ann. %
-
-
-1.10.90.80.80.70.91.111.11.1
Working Capital Turnover Ann.
17.6%
16.7%
2.63.12.41.61.31.21.51.31.31.51.7
Quick Ratio Ann.
-
-
-1.92.43.94.44.64.966.16.44.8
Current Ratio Ann.
-
-
-2.42.94.75.45.45.86.86.77.15.2
Interest Coverage Ratio Ann.
-
-
---------3,788.5670.4
LT Debt To Equity Ann.
-
-
-0.10.10.10.100----
*All financials are in USD Million and price data in USD

Inogen Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Inogen Inc Dec-2025 Cash From Operating Activity is $-11 Million which is growth of -289.7% YoY.

  • NEGATIVE

    Net Cash Flow Inogen Inc Dec-2025 Net Cash Flow is $-13 Million which is growth of -69.9% YoY.

Inogen Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
-11.25.9-3.2-37.523.63740.66060.53138.2
-
-
-26.2-14-59.3-10.9-14.6-25.6-44.1-25-24.4-11.9-29.3
292.6%
63%
24.20.310.4152.14.918.3147.70.4
Cash Plus Cash Eqv. End Of Year Ann.
-17.5%
-13.1%
105117.4125.5187235.5212198196.614392.966.1
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-13.2-7.8-61.6-482413.41.553.350.126.89.2
Cash Plus Cash Eqv. Begin Of Year Ann.
-20.7%
-9.9%
117.4125.5187235.5212198196.614392.966.156.8
Income Tax Paid Supplemental Data Ann.
-15.7%
-
0.30.4-0.51.5-0.21.71.3-0
Interest Paid Supplemental Data Ann.
-
-
--------00
Capex Ann.
-
-
-10.4-17.1-27-21.2-24.1-17.6-6.5-13-10.2-8-12.5
Issuance Of Capital Stock Ann.
-
-
27.2--------
Issuance Of Debt Ann.
-
-
---------
Repayment Of Debt Ann.
-
-
--------0.3-0.3
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-21.6-11.2-30.3-58.8-0.419.434.14750.32325.7
*All financials are in USD Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
7966.7%
2Y CAGR
391.9%
3Y CAGR
292.6%
5Y CAGR
63%
7Y CAGR
4.1%
10Y CAGR
50.7%
Cash from Financing Annual Activity growth is higher than historical averages.